SMAD4 and osteosarcoma: In contrast to our reports, Ma et al.46, 47demonstrate that TAZ enhances tumor growth in osteosarcoma by inducing miR‐224 to downregulate SMAD4, suggesting an oncogenic role for TAZ and miR‐224.